TRAVELLI, Cristina
 Distribuzione geografica
Continente #
NA - Nord America 1.599
EU - Europa 1.464
AS - Asia 850
SA - Sud America 112
Continente sconosciuto - Info sul continente non disponibili 82
AF - Africa 22
OC - Oceania 1
Totale 4.130
Nazione #
US - Stati Uniti d'America 1.532
RU - Federazione Russa 302
IE - Irlanda 255
IT - Italia 231
CN - Cina 230
SG - Singapore 201
DE - Germania 188
SE - Svezia 137
VN - Vietnam 123
HK - Hong Kong 112
BR - Brasile 86
UA - Ucraina 85
FR - Francia 71
IN - India 71
GB - Regno Unito 51
FI - Finlandia 49
CA - Canada 38
TR - Turchia 32
EE - Estonia 17
ID - Indonesia 13
PL - Polonia 13
BE - Belgio 12
ES - Italia 11
AR - Argentina 10
IR - Iran 10
LT - Lituania 10
MX - Messico 10
IQ - Iraq 9
JP - Giappone 9
BD - Bangladesh 7
CZ - Repubblica Ceca 7
ZA - Sudafrica 7
PH - Filippine 6
EC - Ecuador 5
KR - Corea 5
NL - Olanda 5
AT - Austria 4
CR - Costa Rica 4
DK - Danimarca 4
DZ - Algeria 4
PK - Pakistan 4
SA - Arabia Saudita 4
VE - Venezuela 4
CO - Colombia 3
EG - Egitto 3
GR - Grecia 3
JM - Giamaica 3
BJ - Benin 2
CL - Cile 2
GP - Guadalupe 2
GT - Guatemala 2
LB - Libano 2
MD - Moldavia 2
MY - Malesia 2
RO - Romania 2
SN - Senegal 2
SV - El Salvador 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
AU - Australia 1
AZ - Azerbaigian 1
BB - Barbados 1
BG - Bulgaria 1
EU - Europa 1
GA - Gabon 1
HN - Honduras 1
HU - Ungheria 1
IL - Israele 1
KW - Kuwait 1
KZ - Kazakistan 1
LV - Lettonia 1
MA - Marocco 1
NI - Nicaragua 1
PR - Porto Rico 1
PT - Portogallo 1
PY - Paraguay 1
QA - Qatar 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
TM - Turkmenistan 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 4.050
Città #
Dublin 255
Jacksonville 157
Hong Kong 111
San Jose 103
Ashburn 96
Dearborn 83
Singapore 82
Beijing 81
Piemonte 75
Council Bluffs 71
Chandler 54
Wilmington 47
Ann Arbor 45
Los Angeles 38
Ho Chi Minh City 36
Columbus 34
Santa Clara 30
Hanoi 29
Moscow 28
Bremen 27
Lawrence 27
Princeton 27
New York 26
Lauterbourg 24
Munich 24
Ankara 19
Frankfurt am Main 19
San Mateo 17
Dallas 16
Phoenix 15
Toronto 15
Helsinki 14
Houston 14
North Bergen 14
Montreal 13
São Paulo 13
Woodbridge 13
Andover 12
Denver 12
Nanjing 12
Strasbourg 12
Buffalo 11
Chicago 11
Milan 11
Warsaw 11
Brussels 10
Kecioeren 10
Orem 10
Chennai 9
Formigine 9
Redondo Beach 9
Varallo 9
Brooklyn 8
Dong Ket 8
Guangzhou 8
Nuremberg 8
Tokyo 8
Hangzhou 7
Hefei 7
Leawood 7
Poplar 7
Shanghai 7
Atlanta 6
Brno 6
Manchester 6
Turku 6
Zanjan 6
Boardman 5
Chengdu 5
Da Nang 5
Falkenstein 5
Haiphong 5
Johannesburg 5
Kaunas 5
London 5
Mexico City 5
Seoul 5
Stockholm 5
Torino 5
Albano Laziale 4
Baghdad 4
Berlin 4
Brasília 4
Hillsboro 4
Jakarta 4
Nanchang 4
Paris 4
Philadelphia 4
Turin 4
Vaiano Cremasco 4
Athens 3
Bacoli 3
Biên Hòa 3
Boston 3
Can Tho 3
Caracas 3
Charlotte 3
Fairfield 3
Florence 3
Grignasco 3
Totale 2.189
Nome #
Identification of a novel NAMPT inhibitor by combinatorial click chemistry and chemical refinement 200
Design, synthesis, and biological evaluation of combretabenzodiazepines: a novel class of anti-tubulin agents 188
Targeting Transient Receptor Potential Vanilloid 1 (TRPV1) Channel Softly: The Discovery of Passerini Adducts as a Topical Treatment for Inflammatory Skin Disorders 185
Identification of Novel Triazole-Based Nicotinamide Phosphoribosyltransferase (NAMPT) Inhibitors Endowed with Antiproliferative and Antiinflammatory Activity 174
Inhibitors of Nicotinamide Phosphoribosyltransferase, compositions, products and uses thereof. 174
Nicotinamide phosphoribosyltransferase (NAMPT/PBEF/visfatin) is a tumoural cytokine released from melanoma 154
Triazole-curcuminoids: A new class of derivatives for 'tuning' curcumin bioactivities? 150
Nicotinamide phosphoribosyltransferase (NAMPT) inhibitors: novel modulators of antitumor immunity 150
Combretabenzodiazepines: a novel class of antitubulin agents 148
Nicotinamide phosphoribosyltransferase (NAMPT) is over-expressed in melanoma lesions. 145
Data on metabolic stability, aqueous solubility and CYP inhibition of novel triazole-based nicotinamide phosphoribosyltransferase (NAMPT) inhibitors 144
NAMPT: A pleiotropic modulator of monocytes and macrophages 140
Medicinal chemistry of nicotinamide phosphoribosyltransferase (NAMPT) inhibitors. 139
The Cytokine Nicotinamide Phosphoribosyltransferase (eNAMPT; PBEF; Visfatin) Acts as a Natural Antagonist of C-C Chemokine Receptor Type 5 (CCR5) 139
Characterization of NAD uptake in mammalian cells 138
The NAMPT inhibitor FK866 reverts the damage in spinal cord injury 137
Extracellular nicotinamide phosphoribosyltransferase, a new cancer metabokine 135
A novel potent nicotinamide phosphoribosyltransferase inhibitor synthesized via click chemistry 132
Metabolic regulation of suppressive myeloid cells in cancer 131
Increased plasma nicotinamide phosphoribosyltransferase is associated with a hyperproliferative phenotype and restrains disease progression in MPN-associated myelofibrosis 129
Nicotinamide phosphoribosyltransferase (NAMPT/PBEF/visfatin): a new cytokine in tumour progression 122
Insight Into Nicotinamide Adenine Dinucleotide Homeostasis as a Targetable Metabolic Pathway in Colorectal Cancer 120
Extracellular nicotinamide phosphoribosyltransferase boosts IFNγ-induced macrophage polarization independently of TLR4 115
NAD depletion by FK866 induces autophagy 111
Targeting nicotinamide phosphoryltransferase (NAMPT) in inflammatory bowel disease 110
Nicotinamide phosphoribosyltransferase (NAMPT) inhibitors are novel modulators of myeloid-derived suppressor cells 109
Reciprocal potentiation of the antitumoral activities of FK866, an inhibitor of nicotinamide phosphoribosyltransferase, and etoposide or cisplatin in neuroblastoma cells 97
Nicotinamide phosphoribosyltransferase (NAMPT/PBEF/visfatin): a new cytokine in tumour progression 81
NAMPT and NAPRT serum levels predict response to anti-TNF therapy in inflammatory bowel disease 81
null 77
OXER1 and RACK1-associated pathway: a promising drug target for breast cancer progression 75
Totale 4.130
Categoria #
all - tutte 18.499
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.499


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022185 0 0 0 20 16 2 14 5 15 14 30 69
2022/2023603 30 22 33 5 49 61 26 34 279 2 35 27
2023/2024200 23 10 32 9 27 0 47 4 3 1 21 23
2024/2025406 7 9 27 12 18 25 40 36 66 47 17 102
2025/20261.399 73 57 94 249 154 86 144 258 101 98 58 27
2026/2027345 46 95 76 128 0 0 0 0 0 0 0 0
Totale 4.130